Delivery Order SPE2DB22D3009-SPE2DB24FAU44
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,177,428 units of Ondansetron ODT 8 mg tablets. The $4,191.53 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) on October 22, 2024, with a completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,331,556 units of Ondansetron ODT 4 mg Tablets in 30-count packages. The $6,620.80 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), with a completion date of April 22, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $5,001.12, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,564,328,192 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,564,792,670 units of the medication Ondansetron ODT 4 mg Tablet 30s. The $11,305.60 Firm Fixed Price Delivery Order has a completion date of June 4, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,728.10 for the provision of 4,566,088,902 units of the drug Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 15, 2024 and was awarded on October 11, 2024. The contract was issued by the Defense Logistics Agency (DLA), a defense agency, and is not designated with any set-aside requirements. Amerisourcebergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,014,184 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The $4,583.28 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award is for the purchase of 4,567,175,269 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $12,156.98 firm fixed-price delivery order has a completion date of February 6, 2025 and is not designated under any set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,719.98 fixed-price delivery order is for the supply of 4,565,713,305 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet. The contract has a completion date of September 9, 2024 and was awarded on September 6, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,528.76 contract is for the supply of 4,564,885,759 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with an ultimate completion date of June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,817,027 units of the pharmaceutical product Ondansetron ODT 8 mg Tablet in 30-count packages. The contract has a ceiling value of $6,154.92 and is a delivery order with a firm fixed price. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition services for the U.S. Department of Defense. Amerisourcebergen...